A detailed history of Alliancebernstein L.P. transactions in Baxter International Inc stock. As of the latest transaction made, Alliancebernstein L.P. holds 665,137 shares of BAX stock, worth $21.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
665,137
Previous 762,494 12.77%
Holding current value
$21.9 Million
Previous $25.5 Million 0.98%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$32.85 - $40.26 $3.2 Million - $3.92 Million
-97,357 Reduced 12.77%
665,137 $25.3 Million
Q2 2024

Aug 14, 2024

BUY
$32.87 - $43.55 $2.94 Million - $3.9 Million
89,535 Added 13.3%
762,494 $25.5 Million
Q1 2024

May 14, 2024

SELL
$37.88 - $43.77 $5.66 Million - $6.54 Million
-149,374 Reduced 18.16%
672,959 $28.8 Million
Q4 2023

Feb 14, 2024

BUY
$31.71 - $38.95 $3.78 Million - $4.64 Million
119,234 Added 16.96%
822,333 $31.8 Million
Q3 2023

Nov 14, 2023

SELL
$37.32 - $49.29 $14 Million - $18.4 Million
-373,869 Reduced 34.71%
703,099 $26.5 Million
Q2 2023

Aug 15, 2023

SELL
$39.98 - $47.68 $17.5 Million - $20.9 Million
-437,725 Reduced 28.9%
1,076,968 $49.1 Million
Q1 2023

May 15, 2023

BUY
$37.58 - $52.57 $22 Million - $30.7 Million
584,309 Added 62.8%
1,514,693 $61.4 Million
Q4 2022

Feb 14, 2023

SELL
$49.7 - $57.71 $9.38 Million - $10.9 Million
-188,656 Reduced 16.86%
930,384 $47.4 Million
Q3 2022

Nov 15, 2022

BUY
$53.86 - $66.8 $5.13 Million - $6.36 Million
95,222 Added 9.3%
1,119,040 $60.3 Million
Q2 2022

Aug 15, 2022

BUY
$63.83 - $80.0 $10.2 Million - $12.8 Million
159,377 Added 18.44%
1,023,818 $65.8 Million
Q1 2022

May 13, 2022

BUY
$76.85 - $89.45 $19 Million - $22.2 Million
247,824 Added 40.19%
864,441 $67 Million
Q4 2021

Feb 14, 2022

SELL
$74.57 - $87.19 $3.79 Million - $4.43 Million
-50,760 Reduced 7.61%
616,617 $52.9 Million
Q3 2021

Nov 10, 2021

BUY
$73.77 - $83.61 $386,038 - $437,531
5,233 Added 0.79%
667,377 $53.7 Million
Q2 2021

Jul 30, 2021

SELL
$80.5 - $88.01 $2.29 Million - $2.5 Million
-28,418 Reduced 4.12%
662,144 $53.3 Million
Q1 2021

May 06, 2021

SELL
$76.38 - $86.03 $33.8 Million - $38.1 Million
-442,902 Reduced 39.08%
690,562 $58.2 Million
Q4 2020

Feb 08, 2021

SELL
$75.39 - $82.36 $102 Million - $111 Million
-1,350,741 Reduced 54.37%
1,133,464 $90.9 Million
Q3 2020

Nov 12, 2020

BUY
$78.33 - $90.73 $38.8 Million - $45 Million
495,765 Added 24.93%
2,484,205 $200 Million
Q2 2020

Aug 13, 2020

BUY
$78.66 - $94.14 $90.4 Million - $108 Million
1,149,642 Added 137.06%
1,988,440 $171 Million
Q1 2020

May 14, 2020

SELL
$71.57 - $93.3 $1.46 Million - $1.9 Million
-20,356 Reduced 2.37%
838,798 $68.1 Million
Q4 2019

Feb 18, 2020

SELL
$76.7 - $88.45 $311,248 - $358,930
-4,058 Reduced 0.47%
859,154 $71.8 Million
Q3 2019

Nov 14, 2019

BUY
$81.4 - $89.78 $4.67 Million - $5.15 Million
57,372 Added 7.12%
863,212 $75.5 Million
Q2 2019

Aug 14, 2019

SELL
$73.44 - $82.41 $6.6 Million - $7.4 Million
-89,819 Reduced 10.03%
805,840 $66 Million
Q1 2019

May 14, 2019

SELL
$64.48 - $81.31 $516,678 - $651,537
-8,013 Reduced 0.89%
895,659 $72.8 Million
Q4 2018

Feb 13, 2019

BUY
$61.45 - $77.8 $1.69 Million - $2.14 Million
27,546 Added 3.14%
903,672 $59.5 Million
Q3 2018

Nov 08, 2018

SELL
$70.71 - $77.75 $860,964 - $946,684
-12,176 Reduced 1.37%
876,126 $67.5 Million
Q2 2018

Aug 13, 2018

BUY
$63.43 - $75.41 $2.67 Million - $3.17 Million
42,055 Added 4.97%
888,302 $65.6 Million
Q1 2018

May 14, 2018

SELL
$62.56 - $72.26 $1.17 Million - $1.35 Million
-18,684 Reduced 2.16%
846,247 $55 Million
Q4 2017

Feb 13, 2018

SELL
$61.45 - $66.05 $2.23 Million - $2.4 Million
-36,308 Reduced 4.03%
864,931 $55.9 Million
Q3 2017

Nov 13, 2017

BUY
$59.5 - $64.61 $53.6 Million - $58.2 Million
901,239
901,239 $56.6 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.6B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.